Latest Breaking News On - Qiagen company - Page 1 : comparemela.com

Yuwen Han, Jun You, Yun Han, Yinglei Liu, Menghui Huang, Xiaoyan Lu, Jingjing Chen, Yanli Zheng Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Nantong University, Nantong, 226001, Jiangsu Province, People’s Republic of China Correspondence: Yanli Zheng Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Nantong University, No. 6 North Hai-Er-Xiang Road, Chongchuan District, Nantong, 226001, Jiangsu Province, People’s Republic of China Tel +86-0513-85061000 Objective: Cisplatin resistance is one of the main reasons for treatment failure in ovarian cancer (OC). Here, the effects of LINC00184 on cisplatin-resistant OC were studied. Patients and Methods: LINC00184, miR-1305 and CNTN1 expression in tissues from 70 OC patients was determined by qRT-PCR, in situ hybridization and Western blot. OC cell lines and OC cisplatin-resistant cell lines were cultured. Cells were transfected using Lipofectamine 2000 and treated with 100 nM

United statesUnited kingdomEteläuomen läiAssociation betweenLaboratory animalsShanghai institute of cell biologyQiagen companyChinese academy of sciences shanghaiAmbion companySecond affiliated hospital of nantong universityDnasei qiagen companyShanghai experimental animal centerSecond affiliated hospitalNantong universitySitu hybridizationShanghai institute